285 related articles for article (PubMed ID: 31165861)
1. Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.
Shah JA; Lindestam Arlehamn CS; Horne DJ; Sette A; Hawn TR
J Infect Dis; 2019 Aug; 220(7):1091-1098. PubMed ID: 31165861
[TBL] [Abstract][Full Text] [Related]
2. Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosis.
Dutt TS; Karger BR; Fox A; Youssef N; Dadhwal R; Ali MZ; Patterson J; Creissen E; Rampacci E; Cooper SK; Podell BK; Gonzalez-Juarrero M; Obregon-Henao A; Henao-Tamayo M
Cell Rep; 2022 Dec; 41(11):111783. PubMed ID: 36516760
[TBL] [Abstract][Full Text] [Related]
3. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects.
Fritschi N; Curtis N; Ritz N
Paediatr Respir Rev; 2020 Nov; 36():57-64. PubMed ID: 32958428
[TBL] [Abstract][Full Text] [Related]
4. Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
Poyntz HC; Stylianou E; Griffiths KL; Marsay L; Checkley AM; McShane H
Tuberculosis (Edinb); 2014 May; 94(3):226-37. PubMed ID: 24572168
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of human pulmonary infection with nontuberculous mycobacteria.
Marras TK; Daley CL
Clin Chest Med; 2002 Sep; 23(3):553-67. PubMed ID: 12370992
[TBL] [Abstract][Full Text] [Related]
6. BCG Vaccination Induces
Abate G; Hamzabegovic F; Eickhoff CS; Hoft DF
Front Immunol; 2019; 10():234. PubMed ID: 30837992
[TBL] [Abstract][Full Text] [Related]
7. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.
Brandt L; Feino Cunha J; Weinreich Olsen A; Chilima B; Hirsch P; Appelberg R; Andersen P
Infect Immun; 2002 Feb; 70(2):672-8. PubMed ID: 11796598
[TBL] [Abstract][Full Text] [Related]
8. Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions.
Verma D; Chan ED; Ordway DJ
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33207695
[TBL] [Abstract][Full Text] [Related]
9. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment.
Gopalaswamy R; Shanmugam S; Mondal R; Subbian S
J Biomed Sci; 2020 Jun; 27(1):74. PubMed ID: 32552732
[TBL] [Abstract][Full Text] [Related]
10. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
[TBL] [Abstract][Full Text] [Related]
11. Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin.
Edwards ML; Goodrich JM; Muller D; Pollack A; Ziegler JE; Smith DW
J Infect Dis; 1982 May; 145(5):733-41. PubMed ID: 6804577
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte responses to Mycobacterium tuberculosis and Mycobacterium bovis are similar between BCG-vaccinated patients with cystic fibrosis and healthy controls.
Mauch RM; Alves PCM; Levy CE; Ribeiro JD; Ribeiro AF; Høiby N; Nolasco da Silva MT
J Cyst Fibros; 2020 Jul; 19(4):575-579. PubMed ID: 32061516
[TBL] [Abstract][Full Text] [Related]
13. Increased isolation of nontuberculous mycobacteria among TB suspects in Northeastern, Tanzania: public health and diagnostic implications for control programmes.
Hoza AS; Mfinanga SG; Rodloff AC; Moser I; König B
BMC Res Notes; 2016 Feb; 9():109. PubMed ID: 26887928
[TBL] [Abstract][Full Text] [Related]
14. Heterologous Boost Following
Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
Front Immunol; 2018; 9():2439. PubMed ID: 30425711
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in tuberculosis vaccines.
Haile M; Källenius G
Curr Opin Infect Dis; 2005 Jun; 18(3):211-5. PubMed ID: 15864097
[TBL] [Abstract][Full Text] [Related]
16. Increase in Childhood Nontuberculous Mycobacterial Infections After Bacille Calmette-Guérin Coverage Drop: A Nationwide, Population-Based Retrospective Study, Finland, 1995-2016.
Kontturi A; Soini H; Ollgren J; Salo E
Clin Infect Dis; 2018 Sep; 67(8):1256-1261. PubMed ID: 29584893
[TBL] [Abstract][Full Text] [Related]
17. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
[TBL] [Abstract][Full Text] [Related]
18. Effect of non-tuberculous Mycobacteria on host biomarkers potentially relevant for tuberculosis management.
Dhanasekaran S; Jenum S; Stavrum R; Wiker HG; Kenneth J; Vaz M; Doherty TM; Grewal HM;
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3243. PubMed ID: 25329719
[TBL] [Abstract][Full Text] [Related]
19. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
[TBL] [Abstract][Full Text] [Related]
20. Challenges and solutions for a rational vaccine design for TB-endemic regions.
Gowthaman U; Mushtaq K; Tan AC; Rai PK; Jackson DC; Agrewala JN
Crit Rev Microbiol; 2015; 41(3):389-98. PubMed ID: 24495096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
